Lifecore Biomedical Inc. Company Profile
NASDAQ: LFCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lifecore Biomedical at a glance
Lifecore Biomedical Inc. (NASDAQ: LFCR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Chaska, MN. Lifecore Biomedical is led by Mr. Paul Josephs and employs about 382 people. At a market capitalization of $241.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001005286, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Lifecore Biomedical do?
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Business description based on the company's public filings.
Company information
- Legal name
- Lifecore Biomedical Inc.
- Ticker
- NASDAQ: LFCR
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Paul Josephs
- Employees
- 382
- Headquarters
- 3515 Lyman Boulevard, Chaska, MN, United States
- Phone
- 952 368 4300
- Website
- lifecore.com
- Market cap
- $241.46M
- SEC CIK
- 0001005286
- Latest annual report
- 10-K · Aug 7, 2025
Companies similar to Lifecore Biomedical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CAMPCAMP4 Therapeutics Corporation | 3.79 | -5.25% | $237.84M | vs LFCR |
| TTRXTurn Therapeutics Inc. | 8.10 | -6.31% | $247.49M | vs LFCR |
| QTTBQ32 Bio Inc. | 8.34 | -1.65% | $249.57M | vs LFCR |
| PRLDPrelude Therapeutics Incorporated | 3.23 | -0.77% | $258.63M | vs LFCR |
| ALTAltimmune Inc. | 1.33 | -5.67% | $258.80M | vs LFCR |
| EBSEmergent BioSolutions Inc. | 5.05 | -1.94% | $259.65M | vs LFCR |
| ENTAEnanta Pharmaceuticals Inc. | 7.62 | -4.51% | $222.19M | vs LFCR |
| IMRXImmuneering Corporation Class A | 3.38 | -2.03% | $218.90M | vs LFCR |